SEC Form 4 · accession 0001179110-16-033463
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Schoeneck
Officer — President and CEO · Director
Period of report
Dec 23, 2016
Accepted (ET)
Dec 27, 2016 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 23, 2016 | G | 61,207 | $0.00 | D | 0 | D | |
| Common StockF1 | Dec 23, 2016 | G | 61,207 | $0.00 | A | 495,105 | I | By Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transfer of shares to family trust.